Click for best price
Biosimilar Testing Development Services Market Size, Share 2022
This report contains market size and forecasts of Biosimilar Testing and Development Services in Global, including the following market information:
Global Biosimilar Testing and Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Biosimilar Testing and Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Effector Binding Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biosimilar Testing and Development Services include Eurofins Scientific, SGS, Charles River Laboratories, Pharmaceutical Product Development, Exova, Source BioScience, Intertek Group, Medistri and Pace Analytical Services and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biosimilar Testing and Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biosimilar Testing and Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Type, 2021 (%)
Effector Binding
ELISA
Kinetic Binding Assays
ADCC & CDC Cell-Based Assays
Global Biosimilar Testing and Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, by Application, 2021 (%)
PK assay
Tiered Immunogenicity testing
NAb assays
Global Biosimilar Testing and Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Biosimilar Testing and Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilar Testing and Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Biosimilar Testing and Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eurofins Scientific
SGS
Charles River Laboratories
Pharmaceutical Product Development
Exova
Source BioScience
Intertek Group
Medistri
Pace Analytical Services
Sigma-Aldrich
| Report Attributes |
Report Details |
| Report Title |
Biosimilar Testing and Development Services Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Testing and Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Testing and Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Testing and Development Services Overall Market Size
2.1 Global Biosimilar Testing and Development Services Market Size: 2021 VS 2028
2.2 Global Biosimilar Testing and Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Testing and Development Services Players in Global Market
3.2 Top Global Biosimilar Testing and Development Services Companies Ranked by Revenue
3.3 Global Biosimilar Testing and Development Services Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Testing and Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Testing and Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Testing and Development Services Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Testing and Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilar Testing and Development Services Market Size Markets, 2021 & 2028
4.1.2 Effector Binding
4.1.3 ELISA
4.1.4 Kinetic Binding Assays
4.1.5 ADCC & CDC Cell-Based Assays
4.2 By Type - Global Biosimilar Testing and Development Services Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Testing and Development Services Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Testing and Development Services Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Testing and Development Services Market Size, 2021 & 2028
5.1.2 PK assay
5.1.3 Tiered Immunogenicity testing
5.1.4 NAb assays
5.2 By Application - Global Biosimilar Testing and Development Services Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Testing and Development Services Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Testing and Development Services Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Testing and Development Services Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Testing and Development Services Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Testing and Development Services Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Testing and Development Services Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilar Testing and Development Services Revenue, 2017-2028
6.3.2 US Biosimilar Testing and Development Services Market Size, 2017-2028
6.3.3 Canada Biosimilar Testing and Development Services Market Size, 2017-2028
6.3.4 Mexico Biosimilar Testing and Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilar Testing and Development Services Revenue, 2017-2028
6.4.2 Germany Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.3 France Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.4 U.K. Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.5 Italy Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.6 Russia Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.8 Benelux Biosimilar Testing and Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilar Testing and Development Services Revenue, 2017-2028
6.5.2 China Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.3 Japan Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.4 South Korea Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.6 India Biosimilar Testing and Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilar Testing and Development Services Revenue, 2017-2028
6.6.2 Brazil Biosimilar Testing and Development Services Market Size, 2017-2028
6.6.3 Argentina Biosimilar Testing and Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, 2017-2028
6.7.2 Turkey Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.3 Israel Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.5 UAE Biosimilar Testing and Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Corporate Summary
7.1.2 Eurofins Scientific Business Overview
7.1.3 Eurofins Scientific Biosimilar Testing and Development Services Major Product Offerings
7.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.1.5 Eurofins Scientific Key News
7.2 SGS
7.2.1 SGS Corporate Summary
7.2.2 SGS Business Overview
7.2.3 SGS Biosimilar Testing and Development Services Major Product Offerings
7.2.4 SGS Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.2.5 SGS Key News
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Corporate Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Biosimilar Testing and Development Services Major Product Offerings
7.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.3.5 Charles River Laboratories Key News
7.4 Pharmaceutical Product Development
7.4.1 Pharmaceutical Product Development Corporate Summary
7.4.2 Pharmaceutical Product Development Business Overview
7.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Major Product Offerings
7.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.4.5 Pharmaceutical Product Development Key News
7.5 Exova
7.5.1 Exova Corporate Summary
7.5.2 Exova Business Overview
7.5.3 Exova Biosimilar Testing and Development Services Major Product Offerings
7.5.4 Exova Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.5.5 Exova Key News
7.6 Source BioScience
7.6.1 Source BioScience Corporate Summary
7.6.2 Source BioScience Business Overview
7.6.3 Source BioScience Biosimilar Testing and Development Services Major Product Offerings
7.6.4 Source BioScience Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.6.5 Source BioScience Key News
7.7 Intertek Group
7.7.1 Intertek Group Corporate Summary
7.7.2 Intertek Group Business Overview
7.7.3 Intertek Group Biosimilar Testing and Development Services Major Product Offerings
7.7.4 Intertek Group Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.7.5 Intertek Group Key News
7.8 Medistri
7.8.1 Medistri Corporate Summary
7.8.2 Medistri Business Overview
7.8.3 Medistri Biosimilar Testing and Development Services Major Product Offerings
7.8.4 Medistri Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.8.5 Medistri Key News
7.9 Pace Analytical Services
7.9.1 Pace Analytical Services Corporate Summary
7.9.2 Pace Analytical Services Business Overview
7.9.3 Pace Analytical Services Biosimilar Testing and Development Services Major Product Offerings
7.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.9.5 Pace Analytical Services Key News
7.10 Sigma-Aldrich
7.10.1 Sigma-Aldrich Corporate Summary
7.10.2 Sigma-Aldrich Business Overview
7.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Major Product Offerings
7.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.10.5 Sigma-Aldrich Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Biosimilar Testing and Development Services Market Opportunities & Trends in Global Market
Table 2. Biosimilar Testing and Development Services Market Drivers in Global Market
Table 3. Biosimilar Testing and Development Services Market Restraints in Global Market
Table 4. Key Players of Biosimilar Testing and Development Services in Global Market
Table 5. Top Biosimilar Testing and Development Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Biosimilar Testing and Development Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Biosimilar Testing and Development Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Biosimilar Testing and Development Services Product Type
Table 9. List of Global Tier 1 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Biosimilar Testing and Development Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Biosimilar Testing and Development Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Biosimilar Testing and Development Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Biosimilar Testing and Development Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, (US$, Mn), 2023-2028
Table 30. Eurofins Scientific Corporate Summary
Table 31. Eurofins Scientific Biosimilar Testing and Development Services Product Offerings
Table 32. Eurofins Scientific Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 33. SGS Corporate Summary
Table 34. SGS Biosimilar Testing and Development Services Product Offerings
Table 35. SGS Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 36. Charles River Laboratories Corporate Summary
Table 37. Charles River Laboratories Biosimilar Testing and Development Services Product Offerings
Table 38. Charles River Laboratories Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 39. Pharmaceutical Product Development Corporate Summary
Table 40. Pharmaceutical Product Development Biosimilar Testing and Development Services Product Offerings
Table 41. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 42. Exova Corporate Summary
Table 43. Exova Biosimilar Testing and Development Services Product Offerings
Table 44. Exova Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 45. Source BioScience Corporate Summary
Table 46. Source BioScience Biosimilar Testing and Development Services Product Offerings
Table 47. Source BioScience Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 48. Intertek Group Corporate Summary
Table 49. Intertek Group Biosimilar Testing and Development Services Product Offerings
Table 50. Intertek Group Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 51. Medistri Corporate Summary
Table 52. Medistri Biosimilar Testing and Development Services Product Offerings
Table 53. Medistri Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 54. Pace Analytical Services Corporate Summary
Table 55. Pace Analytical Services Biosimilar Testing and Development Services Product Offerings
Table 56. Pace Analytical Services Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
Table 57. Sigma-Aldrich Corporate Summary
Table 58. Sigma-Aldrich Biosimilar Testing and Development Services Product Offerings
Table 59. Sigma-Aldrich Biosimilar Testing and Development Services Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Biosimilar Testing and Development Services Segment by Type in 2021
Figure 2. Biosimilar Testing and Development Services Segment by Application in 2021
Figure 3. Global Biosimilar Testing and Development Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biosimilar Testing and Development Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biosimilar Testing and Development Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Biosimilar Testing and Development Services Revenue in 2021
Figure 8. By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 12. US Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 16. Germany Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 24. China Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 30. Brazil Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
Figure 33. Turkey Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Biosimilar Testing and Development Services Revenue, (US$, Mn), 2017-2028
Figure 37. Eurofins Scientific Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. SGS Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Charles River Laboratories Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Exova Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Source BioScience Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Intertek Group Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Medistri Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pace Analytical Services Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Sigma-Aldrich Biosimilar Testing and Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
